Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Sales | 953 | 203 | 203 | 203 | 204 |
Gross Profit | 953 | 203 | 203 | 203 | 204 |
Operating Expenses | 15,154 | 10,085 | 9,764 | 10,606 | 8,144 |
Operating Income | -14,201 | -9,882 | -9,561 | -10,403 | -7,940 |
Other Income | 117 | 116 | 52 | 12 | -316 |
Pre-tax Income | -14,084 | -9,766 | -9,509 | -10,391 | -8,256 |
Net Income Continuous | -14,084 | -9,766 | -9,509 | -10,391 | -8,256 |
Net Income | $-14,084 | $-9,766 | $-9,509 | $-10,391 | $-8,256 |
EPS Basic Total Ops | -5.50 | -3.80 | -3.80 | 7.60 | -5.00 |
EPS Basic Continuous Ops | -5.48 | -3.82 | -3.82 | 1.63 | -5.04 |
EPS Diluted Total Ops | -5.50 | -3.80 | -3.80 | 7.60 | -5.00 |
EPS Diluted Continuous Ops | -5.48 | -3.82 | -3.82 | 1.63 | -5.04 |
EBITDA(a) | $-13,707 | $-9,477 | $-9,384 | $-10,324 | $-7,891 |